Table 1 Case studies considered
Case Study | Number of populations | Population size | Complexity |
|---|---|---|---|
1) Tumour/Effector | 2 | 5 to 600 | Low |
2) Tumour/Efector/IL-2 | 3 | 104 | Medium |
3) Tumour/Effector/IL-2/ TGF-β | 4 | 104 | High |
Case Study | Number of populations | Population size | Complexity |
|---|---|---|---|
1) Tumour/Effector | 2 | 5 to 600 | Low |
2) Tumour/Efector/IL-2 | 3 | 104 | Medium |
3) Tumour/Effector/IL-2/ TGF-β | 4 | 104 | High |